Skip to content
ppharmaranks
Menu
Class IIOngoing

TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose via… recall

FDA recall D-0531-2025 · initiated May 30, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jul 2, 2025How we research

Advanced Pharmaceutical Technology, Inc. recalled TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml mul… in May 2025 — an FDA Class II recall (D-0531-2025) because Marketed Without an Approved NDA/ANDA.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Marketed Without an Approved NDA/ANDA

Sold unapproved, or found to contain something undeclared

The product should not have been on sale in this form — often a supplement found to contain a hidden prescription drug.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot P-24-1; Exp. 02/28/2027

Quantity recalled: 26 vials

Details

Product
TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01
Recalling company
Advanced Pharmaceutical Technology, Inc.
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
NY, NJ
Initiated
May 30, 2025
FDA report date
Jul 2, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml mul… recalled?
Advanced Pharmaceutical Technology, Inc. recalled TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml mul… in May 2025 — an FDA Class II recall (D-0531-2025) because Marketed Without an Approved NDA/ANDA. May cause temporary or medically reversible harm; low probability of serious harm.
Why was TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml mul… recalled?
Per the FDA enforcement record, the reason for recall D-0531-2025 was: Marketed Without an Approved NDA/ANDA
Is a recalled TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml mul… dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml mul… are affected?
Distributed: NY, NJ. The recall covers these lots — Lot P-24-1; Exp. 02/28/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0531-2025.

Source: openFDA Drug Enforcement record D-0531-2025

← All drug recalls